The panel will consist of reinsurance practitioners with practical experience with either or both limited and full medical and financial underwriting processes. They will compare and contrast the considerations, methodologies and pricing approaches for developing mortality assumptions for a range of market product underwriting situations they have encountered in the marketplace. They will also comment on how to monitor ceding company underwriting processes once they have committed to reinsure these programs.